TG

Tredegar Corporation 2009 Annual Report (10-K) Summary

Business Context and Reporting Period

This report covers the fiscal year ended December 31, 2009. Tredegar Corporation operates through two primary segments: Film Products (plastic films for personal care, packaging, and surface protection) and Aluminum Extrusions (soft-alloy aluminum for construction and industrial markets). The company sold its Canadian aluminum extrusion business in February 2008, which is reported as discontinued operations.

Key Financial Metrics (2009)

Note: Gross profit margin was 17.8% in 2009 compared to 14.0% in 2008.

Material Changes vs. Prior Period

• Revenue Decline: Consolidated sales decreased 26.6% year-over-year. Film Products sales dropped 13.0% due to lower resin costs passed through to customers and volume declines. Aluminum Extrusions sales plummeted 47.8% due to a 32.8% volume decline driven by the recession in the construction sector.
• Profitability Shift: The company reported a net loss of $1.4 million in 2009, a reversal from the $28.9 million profit in 2008. This was primarily driven by a $30.6 million goodwill impairment charge in the Aluminum Extrusions segment.
• Segment Performance:
  • Film Products: Operating profit from ongoing operations increased 19.4% to $64.4 million, aided by cost reductions and a favorable lag in passing through lower resin costs.
  • Aluminum Extrusions: Recorded an operating loss of $6.5 million from ongoing operations, compared to a $10.1 million profit in 2008.
• Balance Sheet Strength: Despite the net loss, the company significantly improved its liquidity position. Cash increased to $90.7 million, and total debt was reduced to $1.2 million, resulting in a net cash position of approximately $89.5 million.

Guidance, Outlook, and Risks

• Outlook: Management expects capital expenditures to rise to approximately $24 million in 2010 for Film Products and $6.4 million for Aluminum Extrusions. The focus for Aluminum Extrusions remains on reducing the breakeven point while investing in capacity expansion at the Carthage, Tennessee facility.
• Key Risks:
  • Customer Concentration: Procter & Gamble (P&G) accounted for approximately 40% of consolidated net sales in 2009. Loss of this customer would have a material adverse effect.
  • Raw Material Volatility: Profitability is sensitive to resin and aluminum prices. While pass-through mechanisms exist, there is a lag (approx. 90 days) that can impact margins.
  • Economic Cyclicality: The Aluminum Extrusions business is highly cyclical and dependent on the U.S. construction market, which remains uncertain.
  • Investment Risk: The company holds speculative investments in a distressed debt fund (Harbinger) and a drug delivery company, which are subject to valuation volatility.
• Unusual Items: The 2009 results included a $5.1 million unrealized gain from the write-up of a drug delivery investment and a $1.8 million gain from earn-out payments on prior asset sales.

Investor Verification Checklist

• Goodwill Impairment: Verify the assumptions used in the $30.6 million goodwill impairment for Aluminum Extrusions and the likelihood of future impairments if the construction market does not recover.
• P&G Dependency: Assess the stability of the relationship with P&G and the company's progress in diversifying its customer base to reduce the 40% concentration risk.
• Resin Cost Pass-Through: Monitor the lag time between raw material cost changes and price adjustments to customers, as this significantly impacts Film Products margins.
• Debt Covenants: Confirm continued compliance with the $300 million revolving credit facility covenants, specifically the leverage ratio and minimum shareholders' equity requirements.
• Investment Valuation: Review the fair value methodology for the drug delivery company investment, which relies on Level 3 inputs and future milestone assumptions.